Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
It’s a new age for science as the US Food and Drug Administration gave its approval for scientists to conduct genetic manipulation in an effort to combat leukemia. This could potentially lead to a cure that does not require extensive chemotherapy, but it is also a new frontier. Gene-editing technology has existed for decades but it wasn’t until recently that it became much cheaper and more accessible.
For all intents and purposes, genetic manipulation can be used for practically any end for as long as it has something to do with organic materials. In the case of humans, the tool called CRISPR can allow scientists to finally start cutting away or adding specific genetic materials that can change a person’s physiology. With regards to leukemia, scientists want to alter cells to make them more resistant to the disease, the New York Times reports.
By creating tougher and more aggressive cells to fight leukemia or other forms of cancer, patients would theoretically never have to take medicine of any kind ever again. They would have a living drug in their system, which would make them practically immune to fatal diseases.
Naturally, there are plenty of concerns when it comes to genetic manipulation that makes getting approval for tests incredibly difficult. The company that finally got approval is Novartis and one of the company’s biggest achievements is 12-year-old Emily Whitehead who is now free of leukemia thanks to the revolutionary treatment.
When speaking to the FDA panel before approval was granted, Emily’s father, Tom Whitehead made a passionate case in favor of the treatment. The premise was simple; approve the treatment and thousands will be saved, Futurism reports.
“I hope that someday all of you on the advisory committee can tell your families for generations that you were part of the process that ended the use of toxic treatments like chemotherapy and radiation as standard treatment, and turned blood cancers into a treatable disease that even after relapse most people survive.”
